Accelerating 510(k) and EU MDR Submissions for an Orthopedic Device Trial Across 3 Regions

A U.S.based medtech company developed a novel orthopedic implant designed to support foot and ankle joint stabilization in patients with degenerative conditions and post-traumatic injuries. Preparing for FDA 510(k) clearance and CE marking, the client needed a partner to conduct a pivotal device safety and performance trial across multiple orthopedic centers.

Client Challenges

Clinvigilant Research Solution

Clinical Strategy & Regulatory Road mapping

Designed and refined the clinical investigation plan (CIP) with clear primary and secondary endpoints, including:

Monitoring, Safety & Reporting

Site Management & Investigator Engagement

eClinical Technology

Outcomes

78 across 5 sites

Total Participants Enrolled

98%

Follow-Up Completion Rate

1 event

(non-serious, resolved)

Device-Related
AE Rate

91.7% of patients showed full implant fusion

Radiographic Success

Filed 4 weeks
after DB lock

FDA 510(k) Submission

Completed and accepted by
NB within 6 weeks

EU MDR CER Submission

Client Testimonial

Chief Clinical Officer
Orthopedic Device Company
Clinvigilant helped us bridge orthopedic science, imaging, and regulatory rigor. Their device trial expertise was vital for both FDA and MDR pathways.

Results?

By blending clinical operations, orthopedic specialization, and regulatory knowledge, Clinvigilant Research enabled this medtech innovator to generate high-integrity clinical data – leading to a fast, successful submission and a strong foundation for post-market entry in two major regions.

Ready to working with All-In-One CRO?

Together, We Accelerate Breakthroughs – Bringing New Treatments to Patients Faster